To compare the total cholesterol and HDL-cholesterol before and after ultra-centrifugation in lipemic samples

Journal of the Pakistan Medical Association

Volumn 55, Issue 6, 2005, Pages 239-242

  Jabbar, Jawaid ^a   Siddiqui, Imran ^a   Raza, Syed Qaiser ^a   Baig, Ayaz ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; HEMOLYSIS; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; JAUNDICE; LIPID ANALYSIS; PROTEIN ELECTROPHORESIS; ULTRACENTRIFUGATION; VENOUS BLOOD; BLOOD; COMPARATIVE STUDY; ECONOMICS; METHODOLOGY;

CHOLESTEROL; CHOLESTEROL, HDL; COST-BENEFIT ANALYSIS; HUMANS; LIPIDS; ULTRACENTRIFUGATION;

EID: 23044472482     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gregory LC. Lipids and lipoproteins. In: Christenson RH, Gregory LC, Johnson LJ. Appleton and Lange's outline review clinical chemistry. New York: McGraw Hill, 2001, pp. 27-50.
2. Champe PC. Lipid metabolism. In: Champe PC, Richard AH Lippincott's illustrated reviews. 2nd edition. Philadelphia: Lippincott, 1997, pp. 163-205.
3. Subaru AA, Abdul KN. Association of high and low density lipoprotein sub-classes to risk of coronary heart disease. Pak Armed Forces Med J 1997; 47:45-7.
4. Schectman G, Sasse EA. Variability of lipid measurement: relevance for the clinician. Clin Chem 1993;39:1495-1503.
5. Gerald RC, Gary LM, Jay S, Robert C. Blood lipid measurements (variation and practical utility). JAMA. 1992;267:1652-9.
6. Hirani S, Dai L, Ishwarlal J. A more valid measurement of low density lipoprotein cholesterol in diabetic patients. Am J Med 1997;102:48-53.
7. Muhammed SB, Zamir AA, Muhammad S. Lipid profile in obesity J Ayub Med Coll 2001;13:31-3.
8. Havel RJ. Role of triglyceride-rich lipoproteins in progression of atherosclerosis. Circulation 1990;81:694-6.
9. Criqui MH, Golomb BA. Epidemiological aspect of lipid abnormalities. Am J Med 1998;105:48S-57S.
10. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992;70:3-9.
11. Gotto AM Jr. Triglyceride as a risk factor for coronary artery disease. Am J Cardiol. 1998;82:22Q-5Q.
12. Benalian P, Cansier C, Hennache G, Khallour O, Bayer P, Duron F. et al. Comparison of a new method for the direct and simultaneous assessment of LDL and HDL-cholesterol with ultracentrifugation and established methods. Clin Chem 2000;46:493-505.
13. Gerald RC, Gary LM, Mary MK, Parvin PW. The effect of errors in lipid measurement and assessment. Curr Cardio Report. 2002;4:501-7.
14. Sehectman G, Patsches M, Sasse EA, Variability in cholesterol measurement: comparison of calculated and direct LDL cholesterol determinations. Clin Chem 1996;42:732-7.
15. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factor in relation to menopause. Q J Med 1992;85:889-96.
16. Kannel WB, Castelli WP. Cholesterol in the prediction of atherosclerotic disease. Framingham study. Ann Intern Med 1979;90:85-91.
17. Castelli WP. Cardiovascular disease in women. Am J Obst Gynaecol. 1988:1046-1060.
18. Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986;32:470-5.
19. Roche / Hitachi 912 analyzer reference guide V1.2 2001 3-4.
20. The Beckman Airfuge. Air-Driven ultracentrifuge Instruction manual, Spinco business center of Beckman instruments. USA: 1995, pp. 1-4.
21. Superko HR, Bachorik PS, Wood PD. High density lipoprotein cholesterol measurements: a help or hindrance in practical clinical medicin. JAMA 1986;256:2714-17.
22. Martin HK, Ronald JE. Interference with clinical laboratory analysis. Clin Chem. 1994;40:1996-2005.
23. Ladenson JH. Patients as their own control: use of the computer to identify Laboratory error. Clin Chem 1975;21:1648-53.
24. Naito HK. Coronary artery disease and disorders of lipid metabolism. In: Kaplan LA, Pesce AJ. (eds). Clinical chemistry theory, analysis and correlation, 3rd ed. New York: Mosby, 1996, pp. 642-81.
25. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P et al. Helsinki heart study: primary prevention trial with Gemfibrozil in middle aged men with dyslipidemia. N Engl J Med 1987;317:1237-45.